Drug Design Group,
Institute of Pharmaceutical Chemistry,
Drug Design Group, Institute of Pharmaceutical Chemistry
Andreas Heine has not added Biography.
If you are Andreas Heine and would like to personalize this page please email our Author Liaison for assistance.
Flexible adaptations in the structure of the tRNA-modifying enzyme tRNA-guanine transglycosylase and their implications for substrate selectivity, reaction mechanism and structure-based drug design.
Chembiochem : a European journal of chemical biology Oct, 2003 | Pubmed ID: 14523925
An old target revisited: two new privileged skeletons and an unexpected binding mode for HIV-protease inhibitors.
Angewandte Chemie (International ed. in English) May, 2005 | Pubmed ID: 15822136
Hydroxyethylene sulfones as a new scaffold to address aspartic proteases: design, synthesis, and structural characterization.
Journal of medicinal chemistry Oct, 2005 | Pubmed ID: 16220977
Unexpected novel binding mode of pyrrolidine-based aspartyl protease inhibitors: design, synthesis and crystal structure in complex with HIV protease.
ChemMedChem Jan, 2006 | Pubmed ID: 16892342
Crystal structures of tRNA-guanine transglycosylase (TGT) in complex with novel and potent inhibitors unravel pronounced induced-fit adaptations and suggest dimer formation upon substrate binding.
Journal of molecular biology Jul, 2007 | Pubmed ID: 17524419
Saccharin inhibits carbonic anhydrases: possible explanation for its unpleasant metallic aftertaste.
Angewandte Chemie (International ed. in English) , 2007 | Pubmed ID: 17705204
Thermodynamic inhibition profile of a cyclopentyl and a cyclohexyl derivative towards thrombin: the same but for different reasons.
Angewandte Chemie (International ed. in English) , 2007 | Pubmed ID: 17902081
Glutamate versus glutamine exchange swaps substrate selectivity in tRNA-guanine transglycosylase: insight into the regulation of substrate selectivity by kinetic and crystallographic studies.
Journal of molecular biology Nov, 2007 | Pubmed ID: 17949745
Structure-guided design of C2-symmetric HIV-1 protease inhibitors based on a pyrrolidine scaffold.
Journal of medicinal chemistry Apr, 2008 | Pubmed ID: 18348517
Structural and kinetic analysis of pyrrolidine-based inhibitors of the drug-resistant Ile84Val mutant of HIV-1 protease.
Journal of molecular biology Nov, 2008 | Pubmed ID: 18692068
Targeting the open-flap conformation of HIV-1 protease with pyrrolidine-based inhibitors.
ChemMedChem Sep, 2008 | Pubmed ID: 18720485
Achiral oligoamines as versatile tool for the development of aspartic protease inhibitors.
Bioorganic & medicinal chemistry Sep, 2008 | Pubmed ID: 18760609
Crystal structure analysis and in silico pKa calculations suggest strong pKa shifts of ligands as driving force for high-affinity binding to TGT.
Chembiochem : a European journal of chemical biology Mar, 2009 | Pubmed ID: 19199329
How to replace the residual solvation shell of polar active site residues to achieve nanomolar inhibition of tRNA-guanine transglycosylase.
ChemMedChem Dec, 2009 | Pubmed ID: 19894214
Fragment-based lead discovery: screening and optimizing fragments for thermolysin inhibition.
ChemMedChem Jun, 2010 | Pubmed ID: 20394106
Structure and substrate docking of a hydroxy(phenyl)pyruvate reductase from the higher plant Coleus blumei Benth.
Acta crystallographica. Section D, Biological crystallography May, 2010 | Pubmed ID: 20445235
Bidentate Zinc chelators for alpha-carbonic anhydrases that produce a trigonal bipyramidal coordination geometry.
ChemMedChem Sep, 2010 | Pubmed ID: 20629007
Stereo- and regioselective azide/alkyne cycloadditions in carbonic anhydrase II via tethering, monitored by crystallography and mass spectrometry.
Chemistry (Weinheim an der Bergstrasse, Germany) May, 2011 | Pubmed ID: 21506176
Two solutions for the same problem: multiple binding modes of pyrrolidine-based HIV-1 protease inhibitors.
Journal of molecular biology Jul, 2011 | Pubmed ID: 21762812
Structural analysis of coniferyl alcohol 9-O-methyltransferase from Linum nodiflorum reveals a novel active-site environment.
Acta crystallographica. Section D, Biological crystallography May, 2013 | Pubmed ID: 23633600
Investigation of specificity determinants in bacterial tRNA-guanine transglycosylase reveals queuine, the substrate of its eucaryotic counterpart, as inhibitor.
PloS one , 2013 | Pubmed ID: 23704982
High resolution crystal structure of Clostridium propionicum β-alanyl-CoA:ammonia lyase, a new member of the "hot dog fold" protein superfamily.
Proteins Sep, 2014 | Pubmed ID: 24623648
Chasing protons: how isothermal titration calorimetry, mutagenesis, and pKa calculations trace the locus of charge in ligand binding to a tRNA-binding enzyme.
Journal of medicinal chemistry Jul, 2014 | Pubmed ID: 24955548
Beyond affinity: enthalpy-entropy factorization unravels complexity of a flat structure-activity relationship for inhibition of a tRNA-modifying enzyme.
Journal of medicinal chemistry Jul, 2014 | Pubmed ID: 24960372
Tracing binding modes in hit-to-lead optimization: chameleon-like poses of aspartic protease inhibitors.
Angewandte Chemie (International ed. in English) Feb, 2015 | Pubmed ID: 25630461
Six Biophysical Screening Methods Miss a Large Proportion of Crystallographically Discovered Fragment Hits: A Case Study.
ACS chemical biology 06, 2016 | Pubmed ID: 27028906
Structures of endothiapepsin-fragment complexes from crystallographic fragment screening using a novel, diverse and affordable 96-compound fragment library.
Acta crystallographica. Section F, Structural biology communications 05, 2016 | Pubmed ID: 27139825
High-Throughput Crystallography: Reliable and Efficient Identification of Fragment Hits.
Structure (London, England : 1993) 08, 2016 | Pubmed ID: 27452405
Occupying a flat subpocket in a tRNA-modifying enzyme with ordered or disordered side chains: Favorable or unfavorable for binding?
Bioorganic & medicinal chemistry 10, 2016 | Pubmed ID: 27501913
A False-Positive Screening Hit in Fragment-Based Lead Discovery: Watch out for the Red Herring.
Angewandte Chemie (International ed. in English) 02, 2017 | Pubmed ID: 28097765
Price for Opening the Transient Specificity Pocket in Human Aldose Reductase upon Ligand Binding: Structural, Thermodynamic, Kinetic, and Computational Analysis.
ACS chemical biology 05, 2017 | Pubmed ID: 28287700
Charges Shift Protonation: Neutron Diffraction Reveals that Aniline and 2-Aminopyridine Become Protonated Upon Binding to Trypsin.
Angewandte Chemie (International ed. in English) 04, 2017 | Pubmed ID: 28371253
Soaking suggests "alternative facts": Only co-crystallization discloses major ligand-induced interface rearrangements of a homodimeric tRNA-binding protein indicating a novel mode-of-inhibition.
PloS one , 2017 | Pubmed ID: 28419165
Homodimer Architecture of QTRT2, the Noncatalytic Subunit of the Eukaryotic tRNA-Guanine Transglycosylase.
Biochemistry 07, 2018 | Pubmed ID: 29862811
Paradoxically, Most Flexible Ligand Binds Most Entropy-Favored: Intriguing Impact of Ligand Flexibility and Solvation on Drug-Kinase Binding.
Journal of medicinal chemistry Jul, 2018 | Pubmed ID: 29909615
Swapping Interface Contacts in the Homodimeric tRNA-Guanine Transglycosylase: An Option for Functional Regulation.
Angewandte Chemie (International ed. in English) 08, 2018 | Pubmed ID: 29927035
Sugar Acetonides are a Superior Motif for Addressing the Large, Solvent-Exposed Ribose-33 Pocket of tRNA-Guanine Transglycosylase.
Chemistry (Weinheim an der Bergstrasse, Germany) Jul, 2018 | Pubmed ID: 29939431
On the Implication of Water on Fragment-to-Ligand Growth in Kinase Binding Thermodynamics.
ChemMedChem 09, 2018 | Pubmed ID: 30058283
Intriguing role of water in protein-ligand binding studied by neutron crystallography on trypsin complexes.
Nature communications 09, 2018 | Pubmed ID: 30177695
Strategies for Late-Stage Optimization: Profiling Thermodynamics by Preorganization and Salt Bridge Shielding.
Journal of medicinal chemistry 11, 2019 | Pubmed ID: 31633354
Surprising Non-Additivity of Methyl Groups in Drug-Kinase Interaction.
ACS chemical biology 12, 2019 | Pubmed ID: 31638770
Conformational Changes in Alkyl Chains Determine the Thermodynamic and Kinetic Binding Profiles of Carbonic Anhydrase Inhibitors.
ACS chemical biology 03, 2020 | Pubmed ID: 32027480
The Influence of Varying Fluorination Patterns on the Thermodynamics and Kinetics of Benzenesulfonamide Binding to Human Carbonic Anhydrase II.
Biomolecules 03, 2020 | Pubmed ID: 32230853
A Proof-of-Concept Fragment Screening of a Hit-Validated 96-Compounds Library against Human Carbonic Anhydrase II.
Biomolecules 03, 2020 | Pubmed ID: 32235320
F2X-Universal and F2X-Entry: Structurally Diverse Compound Libraries for Crystallographic Fragment Screening.
Structure (London, England : 1993) 06, 2020 | Pubmed ID: 32413289
Fragment Binding to Kinase Hinge: If Charge Distribution and Local pK Shifts Mislead Popular Bioisosterism Concepts.
Angewandte Chemie (International ed. in English) 01, 2021 | Pubmed ID: 33021032
Two Methods, One Goal: Structural Differences between Cocrystallization and Crystal Soaking to Discover Ligand Binding Poses.
ChemMedChem Jan, 2021 | Pubmed ID: 33029876
The Importance of Charge in Perturbing the Aromatic Glue Stabilizing the Protein-Protein Interface of Homodimeric tRNA-Guanine Transglycosylase.
ACS chemical biology 11, 2020 | Pubmed ID: 33166460
How a Fragment Draws Attention to Selectivity Discriminating Features between the Related Proteases Trypsin and Thrombin.
Journal of medicinal chemistry Feb, 2021 | Pubmed ID: 33471524
Jan Wollenhaupt1,
Tatjana Barthel1,2,
Gustavo M. A. Lima3,
Alexander Metz4,
Dirk Wallacher5,
Elmir Jagudin3,
Franziska U. Huschmann1,4,
Thomas Hauß1,
Christian G. Feiler1,
Martin Gerlach1,
Michael Hellmig1,
Ronald Förster1,
Michael Steffien1,
Andreas Heine4,
Gerhard Klebe4,
Uwe Mueller1,
Manfred S. Weiss1
1Macromolecular Crystallography, Helmholtz-Zentrum Berlin,
2Structural Biochemistry Group, Institute for Chemistry and Biochemistry, Freie Universität Berlin,
3BioMAX, MAX IV Laboratory,
4Drug Design Group, Institute of Pharmaceutical Chemistry, Philipps-Universität Marburg,
5Department Sample Environment, Helmholtz-Zentrum Berlin
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved